227 related articles for article (PubMed ID: 12374386)
1. New anti-MRSA and anti-VRE carbapenems; synthesis and structure-activity relationships of 1beta-methyl-2-(thiazol-2-ylthio)carbapenems.
Sunagawa M; Itoh M; Kubota K; Sasaki A; Ueda Y; Angehrn P; Bourson A; Goetschi E; Hebeisen P; Then RL
J Antibiot (Tokyo); 2002 Aug; 55(8):722-57. PubMed ID: 12374386
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological properties of a new series of anti-MRSA beta-lactams; 2-(thiazol-2-ylthio)carbapenems.
Shinagawa H; Yamaga H; Houchigai H; Sumita Y; Sunagawa M
Bioorg Med Chem; 1997 Mar; 5(3):601-21. PubMed ID: 9113338
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
Ueda Y; Sunagawa M
Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted thiazolo pyrrolidin-3-ylthio)carbapenem derivatives.
Oh CH; Cho HW; Baek D; Cho JH
Eur J Med Chem; 2002 Sep; 37(9):743-54. PubMed ID: 12350291
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
Patel R; Rouse MS; Piper KE; Steckelberg JM
Diagn Microbiol Infect Dis; 2000 Nov; 38(3):177-9. PubMed ID: 11109018
[TBL] [Abstract][Full Text] [Related]
7. Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B.
Yoshida O; Yasukata T; Sumino Y; Munekage T; Narukawa Y; Nishitani Y
Bioorg Med Chem Lett; 2002 Nov; 12(21):3027-31. PubMed ID: 12372494
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
Nagano R; Shibata K; Adachi Y; Imamura H; Hashizume T; Morishima H
Antimicrob Agents Chemother; 2000 Mar; 44(3):489-95. PubMed ID: 10681308
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel di- and tricationic carbapenems with potent anti-MRSA activity.
Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Shitara E; Iwamatsu K; Atsumi K
Bioorg Med Chem Lett; 2009 Jan; 19(2):447-50. PubMed ID: 19056265
[TBL] [Abstract][Full Text] [Related]
10. CP5484, a novel quaternary carbapenem with potent anti-MRSA activity and reduced toxicity.
Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Matsuhisa E; Takata H; Takata T; Atsumi K; Iwamatsu K; Shitara E
Bioorg Med Chem; 2007 Oct; 15(19):6379-87. PubMed ID: 17681767
[TBL] [Abstract][Full Text] [Related]
11. SM-216601, a novel parenteral 1beta-methylcarbapenem: structure-activity relationships of antibacterial activity and neurotoxicity in mice.
Ueda Y; Itoh M; Sasaki A; Sunagawa M
J Antibiot (Tokyo); 2005 Feb; 58(2):118-40. PubMed ID: 15835724
[TBL] [Abstract][Full Text] [Related]
12. Activity of linezolid against levofloxacin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in Hong Kong.
Ho PL; Ng TK; Yung RW; Que TL; Yip EK; Tse CW; Yuen KY
J Antimicrob Chemother; 2001 Oct; 48(4):590-2. PubMed ID: 11581246
[No Abstract] [Full Text] [Related]
13. Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 1: J-111,347 and related compounds.
Imamura H; Ohtake N; Shimizu A; Jona H; Sato H; Nagano R; Ushijima R; Yamada K; Hashizume T; Morishima H
Bioorg Med Chem Lett; 2000 Jan; 10(2):109-13. PubMed ID: 10673091
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of stilbene oligomers against vancomycin-resistant Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) and their synergism with antibiotics.
Sakagami Y; Sawabe A; Komemushi S; All Z; Tanaka T; Iliya I; Iinuma M
Biocontrol Sci; 2007 Mar; 12(1):7-14. PubMed ID: 17408003
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Garrison MW; Nuemiller JJ
Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.
Shao C; Zhou W; Zhang S; Wei W; Ruan L; Jin Y; Sun X; Huang Y
Bioorg Med Chem Lett; 2011 Nov; 21(22):6732-8. PubMed ID: 21978682
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines.
Weiss WJ; Jacobus NV; Petersen PJ; Testa RT
J Antimicrob Chemother; 1995 Jul; 36(1):225-30. PubMed ID: 8537270
[TBL] [Abstract][Full Text] [Related]
19. Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK).
MartÃnez-Botella G; Breen JN; Duffy JE; Dumas J; Geng B; Gowers IK; Green OM; Guler S; Hentemann MF; Hernandez-Juan FA; Joseph-McCarthy D; Kawatkar S; Larsen NA; Lazari O; Loch JT; Macritchie JA; McKenzie AR; Newman JV; Olivier NB; Otterson LG; Owens AP; Read J; Sheppard DW; Keating TA
J Med Chem; 2012 Nov; 55(22):10010-21. PubMed ID: 23043329
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus.
Cunha BA
Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
